Fiche centre
Charité Universitätsmedizin Berlin
Berlin — Germany
Essais liés2clinical trials
VilleBerlinlocalisation
PaysGermanylocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07159750
Essais cliniques associés
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| TUB-040 | Cancer | Phase 1/2 | NCT06303505 | NAPISTAR1-01 — FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC | RECRUITING |
| CGRP antibody or gepant | Migraine | À vérifier | NCT07159750 | EUREkA — Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine | RECRUITING |